S&P 500 6,976.44 ▲ 37.41 (+0.54%)
DOW 49,407.66 ▲ 515.19 (+1.05%)
NASDAQ 23,592.11 ▲ 130.29 (+0.56%)
US Markets Closed

AFJKU

Aimei Health Technology Co., Ltd

Price Chart
Latest Quote

$67.24

Current Price
Previous Close $67.24
Day High $67.24
Day Low $67.24
Volume 22
Fetched: 2026-02-03T06:00:35
Stock Information
Total Debt $1.66M
Cash Equivalents $3K
Net Income $1.41M
Sector Financial Services
Industry Shell Companies
Exchange NGM
📊 Custom Metrics & Score
Score: 8/42
Debt to Equity 0.00
Debt to Earnings 0.09
Current Ratio 0.04
Quick Ratio 0.03
Return on Equity 3.53%
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
Date Close Volume
2026-01-30 $67.24 0
2026-01-29 $67.24 0
2026-01-28 $67.24 300
2026-01-27 $63.03 0
2026-01-26 $63.03 0
2026-01-23 $63.03 200
2026-01-22 $64.33 0
2026-01-21 $64.33 0
2026-01-20 $64.33 0
2026-01-16 $64.33 0
2026-01-15 $64.33 400
2026-01-14 $65.00 0
2026-01-13 $65.00 0
2026-01-12 $65.00 0
2026-01-09 $65.00 0
2026-01-08 $65.00 1,600
2026-01-07 $66.00 0
2026-01-06 $66.00 0
2026-01-05 $66.00 0
About Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Income Statement (Annual)
Revenue
Metric 2024-12-31
Total Revenue $0
Operating Revenue $0
Expenses
Metric 2024-12-31
Total Expenses $1,064,786
Net Non Operating Interest Income Expense $3,617,001
Operating Expense $1,064,786
Other Operating Expenses $1,064,786
Income & Earnings
Metric 2024-12-31
Net Income From Continuing Operation Net Minority Interest $2,552,215
Net Interest Income $3,617,001
Interest Income $3,617,001
Normalized Income $2,552,215
Net Income From Continuing And Discontinued Operation $2,552,215
Total Operating Income As Reported $-1,064,786
Net Income Common Stockholders $2,552,215
Net Income $2,552,215
Net Income Including Noncontrolling Interests $2,552,215
Net Income Continuous Operations $2,552,215
Pretax Income $2,552,215
Interest Income Non Operating $3,617,001
Operating Income $-1,064,786
Other
Metric 2024-12-31
Tax Effect Of Unusual Items $0
Tax Rate For Calcs $0
Normalized EBITDA (Bullshit earnings) $-1,064,786
EBITDA (Bullshit earnings) $-1,064,786
EBIT $-1,064,786
Diluted NI Availto Com Stockholders $2,552,215
Fetched: 2026-02-02
Balance Sheet (Annual)
Assets
Metric 2024-12-31 2023-12-31
Net Tangible Assets $72,307,939 $69,755,724
Total Assets $73,814,933 $70,470,565
Total Non Current Assets $73,784,549 $69,889,848
Other Non Current Assets $73,784,549 $69,889,848
Current Assets $30,384 $580,717
Prepaid Assets $2,176 $0
Cash Cash Equivalents And Short Term Investments $28,208 $580,717
Cash And Cash Equivalents $28,208 $580,717
Cash Financial $28,208 $580,717
Debt
Metric 2024-12-31 2023-12-31
Net Debt $199,492 -
Total Debt $227,700 -
Current Debt And Capital Lease Obligation $227,700 -
Current Debt $227,700 -
Other Current Borrowings $227,700 -
Liabilities
Metric 2024-12-31 2023-12-31
Total Liabilities Net Minority Interest $1,506,994 $714,841
Total Non Current Liabilities Net Minority Interest $690,000 $690,000
Non Current Deferred Liabilities $690,000 $690,000
Current Liabilities $816,994 $24,841
Payables And Accrued Expenses $589,294 $24,841
Payables $289,780 -
Equity
Metric 2024-12-31 2023-12-31
Common Stock Equity $72,307,939 $69,755,724
Total Equity Gross Minority Interest $72,307,939 $69,755,724
Stockholders Equity $72,307,939 $69,755,724
Retained Earnings $-1,476,823 $-134,337
Other
Metric 2024-12-31 2023-12-31
Ordinary Shares Number $9,026,000 $9,026,000
Share Issued $9,026,000 $9,026,000
Tangible Book Value $72,307,939 $69,755,724
Invested Capital $72,535,639 $69,755,724
Working Capital $-786,610 $555,876
Total Capitalization $72,307,939 $69,755,724
Capital Stock $73,784,762 $69,890,061
Common Stock $73,784,762 $69,890,061
Current Accrued Expenses $299,514 $24,841
Dueto Related Parties Current $289,780 $0
Additional Paid In Capital - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Free Cash Flow
Metric 2024-12-31
Free Cash Flow $-672,289
Operating Activities
Metric 2024-12-31
Operating Cash Flow $-672,289
Cash Flow From Continuing Operating Activities $-672,289
Investing Activities
Metric 2024-12-31
Investing Cash Flow $-277,700
Cash Flow From Continuing Investing Activities $-277,700
Net Other Investing Changes $-277,700
Financing Activities
Metric 2024-12-31
Issuance Of Capital Stock $0
Financing Cash Flow $397,480
Cash Flow From Continuing Financing Activities $397,480
Net Other Financing Charges $119,780
Net Common Stock Issuance $0
Common Stock Issuance $0
Other
Metric 2024-12-31
Repayment Of Debt $0
Issuance Of Debt $277,700
End Cash Position $28,208
Beginning Cash Position $580,717
Changes In Cash $-552,509
Net Issuance Payments Of Debt $277,700
Net Short Term Debt Issuance $277,700
Short Term Debt Payments $0
Short Term Debt Issuance $277,700
Change In Working Capital $392,497
Change In Payables And Accrued Expense $394,673
Change In Accrued Expense $274,673
Change In Payable $120,000
Change In Prepaid Assets $-2,176
Other Non Cash Items $-3,617,001
Net Income From Continuing Operations $2,552,215
Fetched: 2026-02-02